Big Pharma drops sharply ahead of Trump???s tariff announcement
by
Contributor since / Followers
Contributor since / Followers
3 days ago
J Studios Major drugmakers were trading sharply lower on Tuesday as Wall Street is bracing
TEVA
Trump reiterates plan to impose tariffs on pharmaceuticals
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
During a meeting with his cabinet Monday, President Donald Trump said that tariffs on pharmaceuticals
FDA accepts Teva’s application for Uzedy for bipolar I disorder
by
Contributor since / Followers
Contributor since / Followers
1 month ago
Grandbrothers The FDA has accepted a supplemental New Drug Application submitted by Teva (NYSE:TEVA) and
Corcept accused in California of stifling Teva’s generic launch
by
Contributor since / Followers
Contributor since / Followers
1 month ago
DNY59 A group of health insurers has filed a lawsuit against Corcept Therapeutics (NASDAQ:CORT) in
Teva and Alvotech get FDA review acceptance for its proposed biosimilar to Eylea
by
Contributor since / Followers
Contributor since / Followers
2 months ago
Solskin Alvotech (NASDAQ:ALVO) and Teva Pharmaceuticals (NYSE:TEVA) said on Tuesday that the U.S. FDA has
Axsome settles Auvelity patent litigation with Teva
by
Contributor since / Followers
Contributor since / Followers
2 months ago
JHVEPhoto Axsome Therapeutics (NASDAQ:AXSM) stock rallied 15% in morning trading on news it has settled
Teva Pharmaceuticals reports completion of phase 3 trial for Olanzapine LAI in Schizophrenia
by
Contributor since / Followers
Contributor since / Followers
2 months ago
JHVEPhoto/iStock Editorial via Getty Images The pivotal clinical phase 3 trial for the olanzapine Long-Acting
Teva Pharmaceutical announces mixed shelf offering
by
Contributor since / Followers
Contributor since / Followers
2 months ago
Teva Pharmaceutical (NYSE:TEVA) may offer a variety of securities, including American Depositary Shares (ADSs), debt
Teva Pharmaceutical snaps six straight sessions of losses
by
Contributor since / Followers
Contributor since / Followers
2 months ago
JHVEPhoto Teva Pharmaceutical (NYSE:TEVA) shares snapped six straight sessions of losses, as the stock closed
Pharma distributor, generic drug trade groups express concern over tariffs
by
Contributor since / Followers
Contributor since / Followers
2 months ago
krblokhin/iStock Editorial via Getty Images Trade groups representing companies in the pharmaceutical distributor and generic/biosimilar